Capricor, Inc.
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. Source (opens in a new tab)
- Website
- https://www.capricor.com/
- Headquarters
- US